Search
19/02/2023
Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke
Garcia E., Camps-Renom P., Puig N., Fernández-Leon A., Aguilera-Simón A., Benitez-Amaro A., Solé A., Vilades D., Sanchez-Quesada J.L., Martí-Fàbregas J., Jiménez-Xarrié E., Benitez S., Llorente-Cortés V.. Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke. Journal of Translational Medicine. 2023; 21(1)DOI:10.1186/s12967-022-03867-w. PMID:36805772. IF:6.100(Q1/2D).
17/02/2023
A City Surveillance System for Social Health Inequalities: The Case of Barcelona
Borrell C., Palència L., Marí-Dell’Olmo M., Bartoll X., Gotsens M., Pasarín M.I., Artazcoz L., Rodríguez-Sanz M., López M.J., Pérez K.. A City Surveillance System for Social Health Inequalities: The Case of Barcelona. International Journal of Environmental Research and Public Health. 2023; 20(4)DOI:10.3390/ijerph20043536. PMID:36834231. IF:(Q/D).
15/02/2023
Glucocorticoid-based pharmacotherapies preventing PTSD
Florido, A, Velasco, ER, Monari, S, Cano, M, Cardoner, N, Sandi, C, Andero, R, Perez-Caballero, L. Glucocorticoid-based pharmacotherapies preventing PTSD. NEUROPHARMACOLOGY. 2023; 224DOI:10.1016/j.neuropharm.2022.109344. PMID:36402246. IF:4.600(Q1/2D).
15/02/2023
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Shi L., Xu J., Green R., Wretlind A., Homann J., Buckley N.J., Tijms B.M., Vos S.J.B., Lill C.M., Kate M.T., Engelborghs S., Sleegers K., Frisoni G.B., Wallin A., Lleó A., Popp J., Martinez-Lage P., Streffer J., Barkhof F., Zetterberg H., Visser P.J., Lovestone S., Bertram L., Nevado-Holgado A.J., Proitsi P., Legido-Quigley C.. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2023; 19(8)DOI:10.1002/alz.12961. PMID:36790009. IF:13.100(Q1/1D).